Medidata
Cloud platform for clinical trial management, data collection, and regulatory submission in life sciences.
What it does
Medidata is a clinical trial technology platform providing electronic data capture (EDC), clinical trial management (CTMS), randomization, supply chain management, patient recruitment, and AI analytics for pharmaceutical, biotech, and medical device companies. Its Rave AI capabilities include synthetic control arms that use historical clinical trial data to replace or reduce placebo groups, patient dropout prediction that identifies at-risk trial participants before they withdraw, site performance analytics, and protocol optimization that predicts how design changes will affect enrollment timelines and data quality. Medidata is the most widely used clinical trial platform globally, processing data from thousands of active trials.
Why AI-ENHANCED
Medidata is an established clinical trial platform that has meaningfully integrated AI capabilities including synthetic control arms, predictive analytics, and patient risk models into a mature and market-leading clinical data management product.
Best for
Large pharmaceutical companies, global biotechs, and CROs use Medidata as the integrated platform for running global clinical trials - from protocol design through regulatory submission - with AI reducing trial timelines and improving data quality at scale.
Limitations
Setting up Medidata for a new clinical program requires significant configuration, validation, and training — implementation timelines of three to six months are standard for new sponsor organizations.
Medidata is priced for pharmaceutical and biotech companies running multiple trials — smaller biotechs or academic research programs may find the cost prohibitive compared to lighter EDC alternatives.
Synthetic control arm and predictive analytics capabilities are most powerful when Medidata has access to relevant historical trial data — newer organizations or novel indications may see limited AI benefit initially.
Alternatives by segment
| If you need… | Consider instead |
|---|---|
| Lighter EDC for smaller trials | Veeva |
| AI drug discovery upstream | Insilico Medicine |
| Lab informatics and research data | Benchling |
Medidata pricing is not publicly disclosed. Contracts are structured by trial and based on the number of subjects, sites, and data points collected. Enterprise license agreements for large pharma companies are negotiated separately.
2026-03-31
